Phase 4Completed

A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids (ADVANCE)

Investigating New Onset Diabetes Mellitus in Kidney Transplant Recipients Receiving an Advagraf-Based Immunosuppressive Regimen With or Without Corticosteroids - A Multicenter, Two Arm, Randomized, Open Label Clinical Study

Sponsor
Astellas Pharma Inc (Industry)
Enrollment
1,166 enrolled
Conditions
Kidney Transplantation
Interventions
Advagraf; Mycophenolate Mofetil; Simulect; Corticosteroids
Ages
adults, older adults
Registry
NCT01304836, EUCTR2010-019638-28

Full record on ClinicalTrials.gov

From the registry

The purpose of this study is to focus on potential differences in the occurrence of new-onset Diabetes Mellitus (a glucose metabolism disorder) when two different regimens of immunosuppressive treatment are compared.

Primary outcomes

  • Diagnosis of new onset Diabetes Mellitus as per ADA criteria at any point up to 24 weeks after kidney transplantation

History

  1. Last registry update

  2. Primary completion

  3. Registered

  4. Started